血管內動脈瘤修復市場規模、佔有率和成長分析：按產品類型、手術類型、動脈瘤類型、材料類型、最終用戶、應用和地區分類－2026-2033年產業預測

2024 年全球血管內動脈瘤修復市場價值為 33 億美元，預計到 2025 年將成長至 34.6 億美元，到 2033 年將成長至 50.3 億美元，在預測期（2026-2033 年）內複合年成長率為 4.8%。

全球血管內動脈瘤修復市場主要受保險報銷政策驅動，這些政策對醫院的採購決策有顯著影響。美國和德國等地區的保險公司正在採用打包支付模式，以縮短住院時間和減少併發症，促使臨床醫生更傾向於選擇血管內動脈瘤修復術而非傳統開放性手術。這種轉變導致醫療設備出貨量顯著成長，反映出人們對微創技術的日益青睞。此外，製造商也在積極回應，開發創新產品，例如適用於較小血管的低輪廓移植物，擴大了這項技術在區域醫院的應用範圍。這些因素——報銷策略、醫療設備的進步以及地理覆蓋範圍的擴大——共同創造了一個充滿活力的市場環境，促進了對動脈瘤患者的早期療育。

全球血管內動脈瘤修復市場的成長要素

醫療專業人員對微創手術的日益青睞是推動全球血管內動脈瘤修復市場成長的主要動力。這種方法能夠最大限度地減輕患者負擔，縮短住院時間，並降低術後併發症的風險。隨著臨床醫生逐漸認知到使用血管內動脈瘤修復裝置進行精準導管介入治療的優勢，尤其是在處理複雜主動脈病變並降低手術風險方面，這項技術正被大學醫院和社區醫院廣泛接受。對這些技術的日益成長的信心促使醫院投資建設必要的配套基礎設施，從而進一步擴大了血管內修復解決方案的整體市場。

全球血管內動脈瘤修復市場的限制因素

全球血管內動脈瘤修復市場面臨許多限制因素，這些限制因素源自於醫療機構的財務困境。血管內動脈瘤修復器材所需的大量初始投資，加上有限的保險覆蓋範圍，給醫院和醫療機構帶來了沉重的財務壓力。保險公司通常將報銷範圍限制在特定病患小組，導致對重大投資的審查更加嚴格。這種情況阻礙了這些技術的廣泛應用，尤其是在價格敏感市場。因此，採購週期的延誤阻礙了市場成長，需要製定有利的定價策略和政策調整，以減輕醫療機構的財務負擔並支持市場擴張。

全球血管內動脈瘤修復市場趨勢

全球血管內動脈瘤修復術（EVAR）市場正經歷著向微創技術的重大轉變，這主要得益於人們日益重視患者康復和併發症風險。醫療機構正擴大採用EVAR，該技術在提供與傳統開放性手術相當的療效的同時，最大限度地減輕了患者的身體負擔。為了順應此趨勢，醫院正在擴大介入病房，投資先進的影像技術，並將EVAR納入更廣泛病患的標準治療方案中。因此，EVAR正成為血管治療中不可或缺的一部分，徹底改變了動脈瘤的治療方式，並革新了全球的臨床實踐。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 疾病流行病學

全球血管內動脈瘤修復市場規模：依產品類型分類

• 腹部主動脈血管瘤（AAA）血管支架
• 胸主動脈瘤（TAA）血管支架
• 開窗式血管內移植物
• 分支型血管內移植物

全球血管內動脈瘤修復市場規模：依手術類型分類

• 選擇性血管內動脈瘤修復術（EVAR）
• 緊急血管內動脈瘤修復術（EVAR）

全球血管內動脈瘤修復市場規模：依動脈瘤類型分類

• 腹部主動脈血管瘤（AAA）
• 胸主動脈瘤（TAA）
• 腹部主動脈血管瘤（TAAA）

全球血管內動脈瘤修復市場規模：依材料類型分類

• 聚酯接枝
• 基於ePTFE的移植物
• 混合材料

全球血管內動脈瘤修復市場規模：依最終用戶分類

• 醫院
• 心血管中心
• 門診手術中心

全球血管內動脈瘤修復市場規模：按應用領域分類

• 原發性動脈瘤修復
• 再次手術和二次手術

全球血管內動脈瘤修復市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic plc
• WL Gore & Associates, Inc.
• Cook Medical LLC
• Terumo Corporation
• Endologix LLC
• MicroPort Scientific Corporation
• Artivion, Inc.
• Cordis Corporation
• Meril Life Sciences Pvt. Ltd.
• Lepu Medical Technology（Beijing）Co., Ltd.
• Endospan Ltd.
• Braile Biomedica
• Lifetech Scientific Corporation
• Lombard Medical Technologies PLC
• Boston Scientific Corporation
• Eucatech AG
• InSitu Technologies Inc.
• Translumina GmbH
• Bentley InnoMed GmbH
• Vesalio LLC

結論與建議

Global Endovascular Aneurysm Repair Market size was valued at USD 3.30 Billion in 2024 and is poised to grow from USD 3.46 Billion in 2025 to USD 5.03 Billion by 2033, growing at a CAGR of 4.8% during the forecast period (2026-2033).

The global endovascular aneurysm repair market is primarily influenced by reimbursement policies, which significantly impact hospital purchasing decisions. Insurers in regions like the U.S. and Germany have adopted bundled payment models that promote shorter hospital stays and reduced complications, prompting clinicians to favor endovascular aneurysm repair over traditional open surgery. This shift has driven a marked increase in device shipments, reflecting the growing preference for minimally invasive techniques. Additionally, manufacturers are responding with innovations such as low-profile grafts tailored for smaller vessels, broadening the technology's accessibility in community hospitals. Together, these factors of reimbursement strategies, device advancement, and expanded geographical access are fostering a dynamic market environment, facilitating earlier intervention for patients battling aneurysms.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Endovascular Aneurysm Repair market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Endovascular Aneurysm Repair Market Segments Analysis

Global endovascular aneurysm repair market is segmented by product type, procedure type, aneurysm type, material type, end user, application and region. Based on product type, the market is segmented into abdominal aortic aneurysm (AAA) stent grafts, thoracic aortic aneurysm (TAA) stent grafts, fenestrated endovascular grafts and branched endovascular grafts. Based on procedure type, the market is segmented into elective endovascular aneurysm repair (EVAR) and emergency endovascular aneurysm repair (EVAR). Based on aneurysm type, the market is segmented into abdominal aortic aneurysm (AAA), thoracic aortic aneurysm (TAA) and thoracoabdominal aortic aneurysm (TAAA). Based on material type, the market is segmented into polyester-based grafts, eptfe-based grafts and hybrid materials. Based on end user, the market is segmented into hospitals, cardiac & vascular centers and ambulatory surgical centers. Based on application, the market is segmented into primary aneurysm repair and revision & secondary procedures. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Endovascular Aneurysm Repair Market

The shift towards minimally invasive medical procedures among healthcare providers is significantly driving the growth of the Global Endovascular Aneurysm Repair market. This approach minimizes patient trauma, shortens hospital stay durations, and lowers the risk of post-procedure complications. As clinicians recognize the advantages of using endovascular aneurysm repair devices for precise catheter-based interventions, particularly in managing complex aortic lesions with reduced procedural risks, the technology garners wider acceptance across both academic and community hospitals. Increased confidence in these methods encourages hospitals to invest in the necessary infrastructure, further enhancing the overall market for endovascular repair solutions.

Restraints in the Global Endovascular Aneurysm Repair Market

The Global Endovascular Aneurysm Repair market faces several constraints stemming from financial challenges encountered by healthcare organizations. The substantial upfront capital required for endovascular aneurysm repair devices, coupled with limited reimbursement coverage, creates economic pressures for hospitals and providers. Insurers often restrict reimbursement to specific patient groups, leading to heightened scrutiny of large investments. This situation discourages widespread adoption of these technologies, particularly in markets sensitive to pricing. Consequently, slower procurement cycles hinder market growth, necessitating favorable pricing strategies and policy modifications to alleviate the financial burdens on healthcare providers and support the expansion of this market.

Market Trends of the Global Endovascular Aneurysm Repair Market

The global endovascular aneurysm repair (EVAR) market is experiencing a significant shift towards minimally invasive techniques, driven by a growing emphasis on patient recovery and reduced complication risks. Healthcare facilities are increasingly adopting EVAR, recognizing its effectiveness comparable to traditional open repair, while minimizing surgical trauma. This trend has prompted hospitals to expand their interventional suites and invest in advanced imaging technologies, integrating EVAR into standard treatment protocols for a broader patient demographic. As a result, EVAR is becoming an essential component of vascular care, revolutionizing the approach to aneurysm management and reshaping clinical practices globally.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Disease Epidemiology

Global Endovascular Aneurysm Repair Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Abdominal Aortic Aneurysm (AAA) Stent Grafts
• Thoracic Aortic Aneurysm (TAA) Stent Grafts
• Fenestrated Endovascular Grafts
• Branched Endovascular Grafts

Global Endovascular Aneurysm Repair Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Elective Endovascular Aneurysm Repair (EVAR)
• Emergency Endovascular Aneurysm Repair (EVAR)

Global Endovascular Aneurysm Repair Market Size by Aneurysm Type & CAGR (2026-2033)

• Market Overview
• Abdominal Aortic Aneurysm (AAA)
• Thoracic Aortic Aneurysm (TAA)
• Thoracoabdominal Aortic Aneurysm (TAAA)

Global Endovascular Aneurysm Repair Market Size by Material Type & CAGR (2026-2033)

• Market Overview
• Polyester-Based Grafts
• ePTFE-Based Grafts
• Hybrid Materials

Global Endovascular Aneurysm Repair Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac & Vascular Centers
• Ambulatory Surgical Centers

Global Endovascular Aneurysm Repair Market Size by Application & CAGR (2026-2033)

• Market Overview
• Primary Aneurysm Repair
• Revision & Secondary Procedures

Global Endovascular Aneurysm Repair Market Size & CAGR (2026-2033)

• North America (Product Type, Procedure Type, Aneurysm Type, Material Type, End User, Application)
  • US
  • Canada
• Europe (Product Type, Procedure Type, Aneurysm Type, Material Type, End User, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Procedure Type, Aneurysm Type, Material Type, End User, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Procedure Type, Aneurysm Type, Material Type, End User, Application)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Procedure Type, Aneurysm Type, Material Type, End User, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• W. L. Gore & Associates, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artivion, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordis Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endospan Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifetech Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lombard Medical Technologies PLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eucatech AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSitu Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Translumina GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bentley InnoMed GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vesalio LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations